AI71, a pioneering AI company launched by Abu Dhabi’s Advanced Technology Research Council (ATRC) and VentureOne, signed a Memorandum of Understanding (MoU) with the Abu Dhabi Department of Health (DoH) on the sidelines of the World Governments Summit (WGS) 2024.

The robust partnership is set to propel the UAE’s healthcare domain into a new era of innovative breakthroughs through the integration of transformative AI technology. This includes AI71’s medical product RAZI71, powered by Falcon LLM, designed to make clinical decision-making more efficient. Potential use cases include enhancing diagnostic accuracy, personalising treatment plans, and improving patient outcomes through data-driven insights.

The partnership will reinforce the UAE’s focus on utilising Artificial Intelligence for the healthcare sector.

The agreement was signed by Dr. Noura Khamis Al Ghaithi, Under-Secretary of DoH, and Shahab Issa Abu Shahab, Director-General of ATRC.

Speaking on the groundbreaking alliance, Shahab Issa Abu Shahab said, “This partnership between AI71 and the Abu Dhabi Department of Health marks a pivotal moment in further enriching Abu Dhabi’s advanced healthcare offering. With AI71, we're poised to supercharge healthcare delivery using AI innovation. Together, we'll drive transformative advancements, enhance patient care, and shape a more resilient healthcare ecosystem for Abu Dhabi and the wider UAE."

Dr. Noura Al Ghaithi added, "As part of its continued efforts towards setting the stage for a future driven by healthcare technology and innovation, this partnership will offer an array of remarkable features designed to simplify and enrich their healthcare experience.”

AI71 continues to deliver unprecedented impact across enterprises, industries and governments. The collaboration with DoH is a significant step in realising the UAE’s vision of an AI-enabled ecosystem that seamlessly integrates an intelligent infrastructure while introducing AI into critical sectors for sustainable outcomes.